Johnson & Johnson – Healthcare Data News

What is Real-World Evidence and How Does It Help Patients?

A Q&A with Josh Gagne, Vice President and Global Head of Epidemiology, Johnson & Johnson Innovative new medicines and medical technologies undergo robust safety assessments before they are made available...

September 21, 2021January 5, 2022 Competitor News COVID-19 RWE Study

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.

NEW BRUNSWICK, N.J., September 21, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new data reinforcing the strong and long-lasting protection of its COVID-19 vaccine. New data also showed...